Literature DB >> 5947580

Treatment of gout by reduction of uric acid production.

G D Kersley.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5947580      PMCID: PMC2453350          DOI: 10.1136/ard.25.4.353

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  7 in total

1.  EFFECT OF OROTIC ACID ON THE METASTASIS OF MAMMARY TUMORS IN MICE.

Authors:  E W CHU; R A MALMGREN
Journal:  Cancer Res       Date:  1964-05       Impact factor: 12.701

2.  4-HYDROXYPYRAZOLO (3,4-D) PYRIMIDINE (HPP) IN THE TREATMENT OF GOUT: PRELIMINARY OBSERVATIONS.

Authors:  A P HALL; V P HOLLOWAY; J T SCOTT
Journal:  Ann Rheum Dis       Date:  1964-11       Impact factor: 19.103

3.  Uricosuric agents in the treatment of gout.

Authors:  G D KERSLEY; A R GIBBS
Journal:  Ann Rheum Dis       Date:  1960-12       Impact factor: 19.103

4.  Studies with allopurinol (HPP) in patients with tophaceous gout.

Authors:  C J Smyth
Journal:  Arthritis Rheum       Date:  1965-10

5.  The effect of allopurinol (HPP) in the treatment of gout.

Authors:  J B Houpt
Journal:  Arthritis Rheum       Date:  1965-10

6.  Xanthine oxidase inhibitors in the management of gout.

Authors:  J B Wyngaarden
Journal:  Arthritis Rheum       Date:  1965-10

7.  EFFECT OF ALLOPURINOL (4-HYDROXYPYRAZOLO-(3,4-D)PYRIMIDINE) ON SERUM AND URINARY URIC ACID IN PRIMARY AND SECONDARY GOUT.

Authors:  T F YUE; A B GUTMAN
Journal:  Am J Med       Date:  1964-12       Impact factor: 4.965

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.